肾衰合并妇科恶性肿瘤围手术期的临床分析
Clinical Studies of Renal Failure Complicated with Gynecological Malignant Tumor during Perioperative Period
DOI: 10.12677/ACM.2023.133425, PDF,   
作者: 杜文婷:青岛大学,医学部,山东 青岛;王 畅, 陈爱平*:青岛大学附属医院,山东 青岛
关键词: 肾衰血液透析妇科恶性肿瘤围手术期Renal Failure Hemodialysis Gynecological Malignant Tumor Perioperative Period
摘要: 目的:探讨肾衰合并妇科恶性肿瘤行手术治疗的围手术期治疗方法及短期疗效,为临床治疗提供参考。方法:回顾性分析我院7例因合并妇科恶性肿瘤行手术治疗的肾衰透析的患者,总结围手术期的治疗方法。结果:7例患者均在术前48 h内行透析治疗,手术顺利,并于术后3日内恢复透析治疗,平稳度过围手术期。尿素氮、肌酐水平手术前后差别无统计学意义。结论:肾衰合并妇科恶性肿瘤患者是一类特殊的患者,做好围手术期的管理对其预后至关重要。
Abstract: Objective: To explore the perioperative treatment methods and short-term effects of surgical treatment for renal failure complicated with gynecological malignant tumor, and provide reference for clinical treatment. Methods: Analyze 7 cases of renal failure dialysis patients with gynecological malignant tumor undergoing surgical treatment in our hospital, and summarize the treatment methods in the perioperative period. Results: All the 7 patients received dialysis treatment within 48 h before surgery, and the operation was successful, and resumed dialysis treatment within 3 days after surgery, and the perioperative period was stable. There was no significant difference in urea nitrogen and creatinine levels before and after operation. Conclusion: The patients with renal failure complicated with gynecological malignant tumor are special patients, and the management of perioperative period is very important for their prognosis.
文章引用:杜文婷, 王畅, 陈爱平. 肾衰合并妇科恶性肿瘤围手术期的临床分析[J]. 临床医学进展, 2023, 13(3): 3001-3005. https://doi.org/10.12677/ACM.2023.133425

参考文献

[1] Ku, E., Lee, B.J., Wei, J. and Weir, M.R. (2019) Hypertension in CKD: Core Curriculum 2019. American Journal of Kidney Diseases, 74, 120-131. [Google Scholar] [CrossRef] [PubMed]
[2] 方桂莲, 王成付. 多种血液净化联合治疗尿毒症并发症的疗效观察及护理[J]. 安徽医药, 2013, 17(2): 343-345.
[3] 王言奎. 合并肾功能异常的围术期处理[J]. 中国实用妇科与产科杂志, 2007, 23(2): 84-85.
[4] 刘蓓. 维持性血液透析患者妇科手术的适应证和安全性[J]. 透析与人工器官, 2019, 30(1): 1-2+5.
[5] Kaul, T.K., Fields, B.L., Reddy, M.A. and Kahn, D.R. (1994) Cardiac Operations in Patients with End-Stage Renal Disease. The Annals of Thoracic Surgery, 57, 691-696. [Google Scholar] [CrossRef
[6] Klein, D.M., Tornetta, P., Barbera, C. and Neuman, D. (1998) Operative Treatment of Hip Fractures in Patients with Renal Failure. Clinical Orthopaedics and Related Research, 350, 174-178. [Google Scholar] [CrossRef
[7] 邢燕平. 合并慢性肾功能不全妇科患者的围手术期处理[J]. 医学理论与实践, 2006, 19(4): 448-449.
[8] 陈金栋, 侯树勋, 李文锋. 慢性肾功能不全骨科患者的围手术期处理[J]. 中华全科医师杂志, 2007, 6(1): 55-56.
[9] 周宏众, 蒋飞照, 张启瑜. 慢性肾功能不全患者腹部手术的围手术期处理[J]. 中华普通外科杂志, 2002, 17(6): 370.
[10] 孙晖. 慢性肾功能不全患者妇科手术的围手术期处理[J]. 中国煤炭工业医学杂志, 2003, 6(12): 1193-1194.
[11] Carlo, J.O., Phisitkul, P., Phisitkul, K., Reddy, S. and Amendola, A. (2015) Perioperative Implications of End-Stage Renal Disease in Orthopaedic Surgery. The Journal of the American Academy of Orthopaedic Surgeons, 23, 107-118. [Google Scholar] [CrossRef
[12] 郑朝旭, 吴志棉, 谭敏, 陈国泰, 余俊峰. 血液透析患者腹腔镜胆囊切除术的围手术期处理[J]. 世界华人消化杂志, 1999, 7(10): 916-917.
[13] 谢建华. 慢性肾功能不全患者心脏瓣膜置换围手术期的护理[J]. 现代医院, 2002, 2(5): 18.
[14] 马丽, 易娜. 慢性肾功能不全腹膜透析治疗相关感染及处理研究进展[J]. 中国冶金工业医学杂志, 2021, 38(5): 512-513.
[15] 李娜, 李小平, 王悦, 王建六, 魏丽惠. 妇科恶性肿瘤合并肾功能衰竭化疗3例[J]. 实用妇产科杂志, 2017, 33(5): 392-393.
[16] Brosnan, E.M., Weickhard,t A.J., Lu, X., et al. (2014) Drug-Induced Reduction in Estimated Glomerular Filtration Rate in Patients with ALK-Positive Non-Small Cell Lung Cancer Treated with the ALK Inhibitor Crizotinib. Cancer, 120, 664-674. [Google Scholar] [CrossRef] [PubMed]
[17] Matas, A., Kjellstrand, C., Simmons, R., Buselmeier, T. and Najarian, J. (1975) Increased Incidence of Malignancy during Chronic Renal Failure. The Lancet, 305, 883-886. [Google Scholar] [CrossRef
[18] Matuszkiewicz-Rowińska, J., Skórzewska, K., Radowicki, S., et al. (2004) Endometrial Morphology and Pituitary-Gonadal Axis Dysfunction in Women of Reproductive Age Under-going Chronic Haemodialysis—A Multicentre Study. Nephrology Dialysis Transplantation, 19, 2074-2077. [Google Scholar] [CrossRef] [PubMed]